Key Messages ​

• ​The California Department of Public Health (CDPH), CDC, FDA, and Poison Control are investigating the Diamond ShruumzTM brand chocolate bars, cones, and gummies (all flavors and types).
• These products, known as microdose products, have been linked to severe acute illnesses and hospitalizations among consumers in multiple states, including California.
• Any illnesses or adverse effects linked to these products should be reported to the Poison Hotline (1-800-222-1222). The marketing of these products may appeal to youth and young adults.   

​Background

As of June 17, 2024, the FDA has reported a total of 26 illnesses from 16 states including California. Twenty-five (25) of the 26 people have reported seeking medical care and 16 have been hospitalized. No deaths have been reported. The cause of the reported illnesses is not known at this time. CDPH is working closely with Poison Control and local and federal agencies to monitor cases of illness, and to find, test, and remove these products from shelves.

Adverse effects from consuming these products have included central nervous system depression with sedation, seizures, muscle rigidity, clonus, tremor, abnormal heart rate (bradycardia or tachycardia), abnormal blood pressure (hypotension or hypertension), gastrointestinal effects (nausea, vomiting, or abdominal pain), skin flushing, diaphoresis, and metabolic acidosis with increased anion gap. Multiple patients have been hospitalized, with several requiring intubation, mechanical ventilation, and admission to an intensive care unit.

Recommendations

• Health care providers should seek clinical advice from and report suspected cases to the California Poison Control System (1-800-222-1222). Poison Control services are available 24 hours a day, 7 days a week. Providers should also consider retaining urine or blood samples for further testing.
• Patients/consumers should be advised not to eat, sell, or serve any flavor of Diamond Shruumz-brand Chocolate Bars, Cones, or Gummies.

Resources

• Consult the CDC Outbreak Summary for additional recommendations, including diagnostic workup, testing and treatment.
• Consult FDA Investigation details  for images of the product and updates on the investigation.